By iGEM Team Tuebingen
In this podcast, we’ll examine synthetic biology and especially so-called Antimicrobial Peptides (AMPs) from different angles, introduce guests from various backgrounds, talk about different approaches to the topic, and about the ethics of it all.
Tune in every other week to listen to the latest episode!
And of course, thank you for listening!
Impressum at www.igem-tuebingen.org
AMPodcastSep 07, 2021
Ep. 07 | iGEM Team CCU Taiwan on AMPs in their project, overcoming problems, and their experience in the competition
In this episode, we talked to a fellow iGEM team, the iGEM team from CCU Taiwan. They are also utilizing AMPs in their project, however in a completely different way, so you will learn a lot about a different approach to fight the worldwide problem of antibiotic resistance. Hear about what their project and aims were, which issues they were concerned with the most, and how they overcame the problems they encountered. This episode is also a remarkable example of the internationality of iGEM generally as we shared with each other our experience in the competition so far.
As always, thanks for listening to AMPodcast!
Ep. 06 | Prof. Potthast on research ethics, the ethical dimension of projects, and science communication
In this part 2, we continue our interview with Prof. Potthast from the University of Tuebingen. We talk about research ethics in general, what to consider when designing a project with regards to the ethical dimension, and about science communication, for example, during the COVID pandemic.
As always, thank you for listening!
Ep. 05 | Prof. Potthast on bioethics and the limits of synthetic biology
This is part 1 of our interview with Prof. Potthast, who is a bioethicist at the IZEW, the ethics institute at the University of Tuebingen. We are talking about the general difference between ethics and morality, and the boundaries of bioethics. This includes how to schedule a scientific project to be ethically viable, and the limits of synthetic biology.
As always, thank you for listening!
Ep. 04 | Jun.-Prof. Dr. Andreas Dräger on systems biology and fighting antimicrobial-resistant pathogens
This week we are talking to Jun.-Prof. Dr. Andreas Dräger and how he is developing computational models for fighting antimicrobial-resistant pathogens and other diseases. We learn about his current work, what systems biology actually is, and what we should look out for in the future. If you want to find out more, check out his YouTube channel at: https://www.youtube.com/c/systemsbiology
Thank you for listening!
Ep. 03 | Prof. Nadine Ziemert on bioinformatics-assisted discovery of new medical compounds
In this episode, we talk to Prof. Nadine Ziemert, who is a researcher at the University of Tuebingen.
Her field is the bioinformatics-focused search for new biomedical compounds, especially through the identification of secondary metabolite gene clusters, which encode for the synthesis of different bioactive compounds such as antibiotics. We also talk about potentially interesting organisms, that could be important sources for these novel compounds.
As always thank you for listening! :)
Ep. 02 | Dr. Üner Kolukisaoglu on Plant Bioscience, Ethics in Biotechnology and Science Communication
In this episode, we are speaking to Dr. Üner Kolukisaoglu, who is a researcher at the Center for Plant Molecular Biology in Tuebingen and a lecturer at the University of Tuebingen.
Topics include his research in Plant Biology, Ethics in Biotechnology including European Legislation, and Science Communication regarding Biotechnology.
As always, thank you for listening. :)
Ep. 01 | Our project for the iGEM competition, anti-microbial peptides, and cyclotides
Listen to the very first episode of the AMPodcast!
In this episode, we will talk about our project for this year's iGEM competition. Meet 4 of our motivated team members and learn more about cyclotides, a special class of extraordinarily stable proteins, antimicrobial peptides (AMPs), a class of proteins with antibacterial effects, and how they could be useful to combat the ever-growing crisis of antibiotic resistance.
iGEM Team Tuebingen
Auf der Morgenstelle 28
Consumer dispute resolution/universal arbitration board:
We are not willing or obliged to participate in dispute resolution proceedings before a consumer arbitration board.